O

OliPass Corp
KOSDAQ:244460

Watchlist Manager
OliPass Corp
KOSDAQ:244460
Watchlist
Price: 1 651 KRW -13.92%
Market Cap: 9B KRW

Gross Margin
OliPass Corp

62.4%
Current
90%
Average
63.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
62.4%
=
Gross Profit
788.9m
/
Revenue
1.3B

Gross Margin Across Competitors

No Stocks Found

OliPass Corp
Glance View

Market Cap
9B KRW
Industry
Biotechnology

OliPass Corp. develops biological products. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2019-09-20. The firm principally manufactures and sells nonopioid analgesic, hyperlipidemia medicine, ocular angiogenesis inhibitor, duchenne dystrophy medicine, cancer immunotherapy medicine and other products. In addition, the Company researches, develops and sells functional cosmetics through the artificial gene platform technology.

Intrinsic Value
1 677.96 KRW
Undervaluation 2%
Intrinsic Value
Price
O
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
62.4%
=
Gross Profit
788.9m
/
Revenue
1.3B
What is the Gross Margin of OliPass Corp?

Based on OliPass Corp's most recent financial statements, the company has Gross Margin of 62.4%.

Back to Top